Atara Biotherapeutics, Inc. (LON:0HIY)
London · Delayed Price · Currency is GBP · Price in USD 11.92
-0.13 (-1.07%)
At close: Sep 12, 2025
Atara Biotherapeutics Market Cap
Atara Biotherapeutics has a market cap or net worth of 59.58 million as of September 18, 2025. Its market cap has increased by 109.61% in one year.
Market Cap
59.58M
Enterprise Value
56.18M
Revenue
137.71M
Ranking
n/a
PE Ratio
14.09
Stock Price
11.92
Market Cap Chart
Since October 17, 2014, Atara Biotherapeutics's market cap has decreased from 144.86M to 59.58M, a decrease of -58.87%. That is a compound annual growth rate of -7.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 59.58M | -2.70% |
| Dec 31, 2024 | 61.24M | 49.24% |
| Dec 29, 2023 | 41.03M | -84.11% |
| Dec 30, 2022 | 258.28M | -74.90% |
| Dec 31, 2021 | 1.03B | -13.57% |
| Dec 31, 2020 | 1.19B | 76.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.00B |
| GSK plc | 59.54B |
| Haleon | 31.92B |
| Smith & Nephew | 12.02B |
| ConvaTec Group | 4.70B |
| Hikma Pharmaceuticals | 3.56B |
| HUTCHMED (China) | 2.15B |
| Genus | 1.65B |